Chris Schaefer

Chris Schaefer is an accomplished finance executive currently serving as Chief Financial Officer at CAQH since April 2024. Prior to this, Chris held the position of Senior Vice President of Corporate Development at PharMerica from September 2013 to May 2024, where significant achievements included leading corporate strategy for a $6.0 billion revenue organization and completing over 50 transactions, which tripled company annual revenue. Previous roles include Director of Healthcare Investment Banking at CIT Healthcare, Business Development at Boston Heart Diagnostics, Vice President at Thomas Weisel Partners, Associate at UBS Investment Bank, Associate at Robertson Stephens, and Analyst at Deutsche Bank. Chris holds an AB in Economics, cum laude, from Harvard University and an MBA in Finance and Marketing from NYU Stern School of Business.